SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-002127
Filing Date
2017-01-27
Accepted
2017-01-27 17:56:04
Documents
2
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6508
2 EX-24 DOCUMENT attachment1.htm EX-24 4035
  Complete submission text file 0000899243-17-002127.txt   11973
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SERES THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Hashad Wael (Reporting) CIK: 0001663009 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 17554958